CMA to continue focus on digital markets and pharmaceuticals
The enforcement chief of the UK’s Competition and Markets Authority today said there are obvious public benefits to focusing on digital and pharmaceutical markets.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.